CSIMarket
 
China Jo Jo Drugstores Holdings Inc  (NASDAQ: CJJD)
 

China Jo Jo Drugstores Holdings Inc's Customers Performance

CJJD



 
CJJD's Source of Revenues During the corresponding time, China Jo Jo Drugstores Holdings Inc While revenue at the China Jo Jo Drugstores Holdings Inc's corporate clients

List of CJJD Customers




for the same period China Jo Jo Drugstores Holdings Inc

List of CJJD Customers

China Jo Jo Drugstores Holdings Inc's Business Units






China Jo Jo Drugstores Holdings Inc's Comment on Sales, Marketing and Customers



The company’s revenue depends significantly on a limited number of key customers, which may vary annually. A substantial portion of revenue is expected to continue from the supply relationship between Jiuxin Medicine and Jiuzhou Pharmacy and its associated clinics. Challenges are anticipated in recovering accounts receivable from Jiuzhou Pharmacy following Restructuring Transactions. The wholesale business faces challenges including limited bargaining power, pricing volatility, and the need for ongoing investment in platforms, customer acquisition, and management. Online sales rely heavily on third-party electronic platforms, which may limit growth or have adverse effects if these platforms fail. The online business must obtain and maintain necessary assets, licenses, qualified personnel, and regulatory approvals under China’s Internet business regulations. The company operates in the pharmaceutical market in China, which is affected by the presence of counterfeit products.





China Jo Jo Drugstores Holdings Inc’s Comment on Sales, Marketing and Customers


The company’s revenue depends significantly on a limited number of key customers, which may vary annually. A substantial portion of revenue is expected to continue from the supply relationship between Jiuxin Medicine and Jiuzhou Pharmacy and its associated clinics. Challenges are anticipated in recovering accounts receivable from Jiuzhou Pharmacy following Restructuring Transactions. The wholesale business faces challenges including limited bargaining power, pricing volatility, and the need for ongoing investment in platforms, customer acquisition, and management. Online sales rely heavily on third-party electronic platforms, which may limit growth or have adverse effects if these platforms fail. The online business must obtain and maintain necessary assets, licenses, qualified personnel, and regulatory approvals under China’s Internet business regulations. The company operates in the pharmaceutical market in China, which is affected by the presence of counterfeit products.








CJJD's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
China Jo Jo Drugstores Holdings Inc 110.46 132.16 -1.25 64
SUBTOTAL 0.00 0.00 0.00 -

Sources: China Jo Jo Drugstores Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: China Jo Jo Drugstores Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on China Jo Jo Drugstores Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.